References
- CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral densityJAMA200329017293814519707
- ChrischillesEAButlerCDDavisCSA model of lifetime osteoporosis impactArch Intern Med19911512026321929691
- EttingerBEnsrudKEWallaceREffects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trialObstet Gynecol20041044435115339752
- EttingerBPressmanAContinuation of postmenopausal hormone replacement therapy in large health maintenance organization: transdermal matrix patch versus oral estrogen therapyAm J Manag Care199957798510538456
- GirdlerSSHinderliterALWellsECTransdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effectsObstet Gynecol20041031698014704262
- GreendaleGAReboussinBAHoganPSymptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions TrialObstet Gynecol19989298289840563
- HoJYChenMJSheuWHDifferential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal womenHum Reprod20062127152016807281
- JohnellOKanisJAAn estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporos Int20061717263316983459
- MansonJEAllisonMARossouwJEEstrogen therapy and coronary-artery calcificationNew Engl J Med2007356259160217582069
- NotelovitzMCasselDHilleDEfficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopauseAm J Obstet Gynecol200018271210649149
- RazRStammWEA controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infectionsN Engl J Med199332975368350884
- RichmanSEdusaVFadielALow-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapyMenopause2006131485516607111
- SamsioeGTransdermal hormone therapy: gels and patchesClimacteric200473475615799606
- ScarabinP-YOgerEPlu-BureauGDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet20033624283212927428
- ShulmanLPThe menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?J Fam Pract20047SupplS131715251108
- ScarabinPYOgerEPlu-BureauGDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet20033624283212927428
- WarmingLRavnPChristiansenCLevonorgestrel and 17β-estradiol given transdermally for the prevention of postmenopausal osteoporosisMaturitas200550788515653003
- Writing Group for the Pepi TrialEffects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trialJAMA19962761389968892713